BACKGROUND/AIM: Primary squamous cell carcinoma of the parotid gland (pPSCC) is a rare tumor, accounting for less than 3% of all parotid carcinomas. There is no general consensus on the management of this tumor, since clinical experience for pPSCC is minimal. Moreover, pPSCC is often misdiagnosed for metastatic cutaneous carcinoma. In our study, we focused on evaluating its biological and clinical characteristics, treatment results and prognosis. We proposed an update on diagnostic and therapeutic management of pPSCC. PATIENTS AND METHODS: The retrospective cohort included 18 patients diagnosed and treated for pPSCC in three tertiary head and neck centers between 2008 and 2022. We retrospectively evaluated their prognosis and established a therapeutic recommendation after analyzing our own and previously published data. RESULTS: Fourteen of 18 tumors were diagnosed in stage IV. Five-year overall survival was 36 months. Six patients received palliative therapy. Twelve patients underwent parotidectomy, neck dissection, and adjuvant radiotherapy. Remission was achieved in 8 patients (follow-up interval 3-56 months). One patient died with recurrent disease. The others are alive and in complete remission. CONCLUSION: The definitive diagnosis of pPSCC must meet the histological and clinical criteria. First of all, the metastatic origin of the tumor must be excluded. Five-year survival of this very aggressive tumor does not exceed 50%. Without surgery, the prognosis is poor. The best results, irrespective of tumor stage, are achieved with surgery. Therefore, a total parotidectomy, neck dissection (therapeutic or elective) and adjuvant radiotherapy are indicated for all resectable tumors.

Department of Otorhinolaryngology and Head and Neck Surgery Hospital AGEL Novy Jicin a s Novy Jicin Czech Republic

Department of Otorhinolaryngology and Head and Neck Surgery Motol University Hospital 1st Faculty of Medicine Charles University Prague Czech Republic

Department of Otorhinolaryngology and Head and Neck Surgery University Hospital Olomouc Faculty of Medicine and Dentistry Palacký University Olomouc Olomouc Czech Republic

Department of Otorhinolaryngology and Head and Neck Surgery University Hospital Olomouc Faculty of Medicine and Dentistry Palacký University Olomouc Olomouc Czech Republic;

See more in PubMed

Fang Q, Wu J, Liu F. Oncologic outcome and potential prognostic factors in primary squamous cell carcinoma of the parotid gland. BMC Cancer. 2019;19(1):752. doi: 10.1186/s12885-019-5969-6. PubMed DOI PMC

Speight PM, Barrett AW. Salivary gland tumours. Oral Dis. 2002;8(5):229–240. doi: 10.1034/j.1601-0825.2002.02870.x. PubMed DOI

Jo U, Song JS, Choi SH, Nam SY, Kim SY, Cho KJ. Primary squamous cell carcinoma of the salivary gland: immunohistochemical analysis and comparison with metastatic squamous cell carcinoma. J Pathol Transl Med. 2020;54(6):489–496. doi: 10.4132/jptm.2020.07.19. PubMed DOI PMC

Li L, Zhang D, Ma F. Nomogram-based prediction of overall and disease-specific survival in patients with postoperative major salivary gland squamous cell carcinoma. Technol Cancer Res Treat. 2022;21:15330338221117405. doi: 10.1177/15330338221117405. PubMed DOI PMC

Shemen LJ, Huvos AG, Spiro RH. Squamous cell carcinoma of salivary gland origin. Head Neck Surg. 1987;9(4):235–240. doi: 10.1002/hed.2890090407. PubMed DOI

Manvikar V, Ramulu S, Ravishanker ST, Chakravarthy C. Squamous cell carcinoma of submandibular salivary gland: A rare case report. J Oral Maxillofac Pathol. 2014;18(2):299–302. doi: 10.4103/0973-029X.140909. PubMed DOI PMC

Brennand-Roper MJ, Pring M, Hughes CW, Thomas S, Eveson JW. Minor salivary gland squamous cell carcinoma of the lower lip demonstrating striking perineural invasion. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2010;110(4):e28–e32. doi: 10.1016/j.tripleo.2010.04.048. PubMed DOI

Araya J, Martinez R, Niklander S, Marshall M, Esguep A. Incidence and prevalence of salivary gland tumours in Valparaiso, Chile. Med Oral Patol Oral Cir Bucal. 2015;20(5):e532–e539. doi: 10.4317/medoral.20337. PubMed DOI PMC

Pfisterer MJ, Vazquez A, Mady LJ, Khan MN, Baredes S, Eloy JA. Squamous cell carcinoma of the parotid gland: A population-based analysis of 2545 cases. Am J Otolaryngol. 2014;35(4):469–475. doi: 10.1016/j.amjoto.2014.03.003. PubMed DOI

Ying YM, Johnson JT, Myers EN. Squamous cell carcinoma of the parotid gland. Head Neck. 2006;28(7):626–632. doi: 10.1002/hed.20360. PubMed DOI

Verim A, Çalım ÖF, Düzcı Yüksel Ö, Naiboğlu B, Tepe Karaca Ç. Parotid gland mass as the presenting symptom of nasopharyngeal carcinoma. Med Bull Haseki. 2014;52:130–132. doi: 10.4274/Haseki.1436. DOI

Akhtar K, Ray PS, Sherwani R, Siddiqui S. Primary squamous cell carcinoma of the parotid gland: a rare entity. BMJ Case Rep. 2013;2013:bcr2013009467. doi: 10.1136/bcr-2013-009467. PubMed DOI PMC

Pisani P, Krengli M, Ramponi A, Pia F. [Parotid metastases: a review of the literature and case reports] Acta Otorhinolaryngol Ital 12 Suppl. 1993;37:1–28. PubMed

Seifert G, Hennings K, Caselitz J. Metastatic tumors to the parotid and submandibular glands. Pathol Res Pract. 1986;181(6):684–692. doi: 10.1016/S0344-0338(86)80044-9. PubMed DOI

Edafe O, Hughes B, Tsirevelou P, Goswamy J, Kumar R. Understanding primary parotid squamous cell carcinoma – A systematic review. Surgeon. 2020;18(1):44–48. doi: 10.1016/j.surge.2019.03.006. PubMed DOI

Aboziada MA, Eisbruch A. Parotid squamous cell carcinoma: Is it a primary or secondary. J Clin Oncol. 2011;29(15_suppl):e16002–e16002. doi: 10.1200/jco.2011.29.15_suppl.e16002. DOI

Flynn MB, Maguire S, Martinez S, Tesmer T. Primary squamous cell carcinoma of the parotid gland: The importance of correct histological diagnosis. Ann Surg Oncol. 1999;6(8):768–770. doi: 10.1007/s10434-999-0768-y. PubMed DOI

Mezi S, Pomati G, Botticelli A, De Felice F, Musio D, Della Monaca M, Amirhassankhani S, Vullo F, Cerbelli B, Carletti R, Di Gioia C, Catalano C, Valentini V, Tombolini V, Della Rocca C, Marchetti P. Primary squamous cell carcinoma of major salivary gland: “Sapienza Head and Neck Unit” clinical recommendations. Rare Tumors. 2020;12:2036361320973526. doi: 10.1177/2036361320973526. PubMed DOI PMC

Franzen A, Lieder A, Guenzel T, Buchali A. The heterogenicity of parotid gland squamous cell carcinoma: a study of 49 patients. In Vivo. 2019;33(6):2001–2006. doi: 10.21873/invivo.11696. PubMed DOI PMC

Lee S, Kim GE, Park CS, Choi EC, Yang W, Lee CG, Keum KC, Kim YB, Suh CO. Primary squamous cell carcinoma of the parotid gland. Am J Otolaryngol. 2001;22(6):400–406. doi: 10.1053/ajot.2001.28068. PubMed DOI

Xiao M, Liu J, You Y, Yang X, Wang Y. Primary squamous cell carcinoma of the parotid gland: clinicopathological characteristics, treatment, and prognosis. Int J Oral Maxillofac Surg. 2021;50(2):151–157. doi: 10.1016/j.ijom.2020.06.010. PubMed DOI

Chen MM, Roman SA, Sosa JA, Judson BL. Prognostic factors for squamous cell cancer of the parotid gland: An analysis of 2104 patients. Head Neck. 2015;37(1):1–7. doi: 10.1002/hed.23566. PubMed DOI

Bron LP, Traynor SJ, McNeil EB, O’Brien CJ. Primary and metastatic cancer of the parotid: comparison of clinical behavior in 232 cases. Laryngoscope. 2003;113(6):1070–1075. doi: 10.1097/00005537-200306000-00029. PubMed DOI

Khurana VG, Mentis DH, O’Brien CJ, Hurst TL, Stevens GN, Packham NA. Parotid and neck metastases from cutaneous squamous cell carcinoma of the head and neck. Am J Surg. 1995;170(5):446–450. doi: 10.1016/s0002-9610(99)80326-2. PubMed DOI

Hinerman RW, Indelicato DJ, Amdur RJ, Morris CG, Werning JW, Vaysberg M, Kirwan J, Mendenhall WM. Cutaneous squamous cell carcinoma metastatic to parotid-area lymph nodes. Laryngoscope. 2008;118(11):1989–1996. doi: 10.1097/MLG.0b013e318180642b. PubMed DOI

Taylor BW Jr, Brant TA, Mendenhall NP, Mendenhall WM, Cassisi NJ, Stringer SP, Million RR. Carcinoma of the skin metastatic to parotid area lymph nodes. Head Neck. 1991;13(5):427–433. doi: 10.1002/hed.2880130510. PubMed DOI

Dona E, Veness MJ, Cakir B, Morgan GJ. Metastatic cutaneous squamous cell carcinoma to the parotid: the role of surgery and adjuvant radiotherapy to achieve best outcome. ANZ J Surg. 2003;73(9):692–696. doi: 10.1046/j.1445-2197.2003.02737.x. PubMed DOI

O’Hara J, Ferlito A, Takes RP, Rinaldo A, Strojan P, Shaha AR, Rodrigo JP, Paleri V. Cutaneous squamous cell carcinoma of the head and neck metastasising to the parotid gland—a review of current recommendations. Head Neck. 2011;33(12):1789–1795. doi: 10.1002/hed.21583. PubMed DOI

Li LJ, Li Y, Wen YM, Liu H, Zhao HW. Clinical analysis of salivary gland tumor cases in West China in past 50 years. Oral Oncol. 2008;44(2):187–192. doi: 10.1016/j.oraloncology.2007.01.016. PubMed DOI

Del Signore AG, Megwalu UC. The rising incidence of major salivary gland cancer in the United States. Ear Nose Throat J. 2017;96(3):E13–E16. doi: 10.1177/014556131709600319. PubMed DOI

Taxy JB. Squamous carcinoma in a major salivary gland. Arch Pathol Lab Med. 2001;125(6):740–745. doi: 10.5858/2001-125-0740-SCIAMS. PubMed DOI

Gao M, Hao Y, Huang M, Ma D, Chen Y, Luo H, Gao Y, Cao Z, Peng X, Yu G. Salivary gland tumours in a northern Chinese population: a 50-year retrospective study of 7190 cases. Int J Oral Maxillofac Surg. 2017;46(3):343–349. doi: 10.1016/j.ijom.2016.09.021. PubMed DOI

Gaughan RK, Olsen KD, Lewis JE, Richtsmeier WJ. Primary squamous cell carcinoma of the parotid gland. Arch Otolaryngol Head Neck Surg. 1992;118:798–801. doi: 10.1001/archotol.1992.01880080020006. PubMed DOI

Sterman BM, Kraus DH, Sebek BA, Tucker HM. Primary squamous cell carcinoma of the parotid gland. Laryngoscope. 1990;100(2):146–148. doi: 10.1288/00005537-199002000-00007. PubMed DOI

Wang L, Li H, Yang Z, Chen W, Zhang Q. Outcomes of primary squamous cell carcinoma of major salivary glands treated by surgery with or without postoperative radiotherapy. J Oral Maxillofac Surg. 2015;73(9):1860–1864. doi: 10.1016/j.joms.2015.03.016. PubMed DOI

Ch’ng S, Maitra A, Lea R, Brasch H, Tan ST. Parotid metastasis – An independent prognostic factor for head and neck cutaneous squamous cell carcinoma. J Plast Reconstr Aesthet Surg. 2006;59(12):1288–1293. doi: 10.1016/j.bjps.2006.03.043. PubMed DOI

Palme CE, O’Brien CJ, Veness MJ, McNeil EB, Bron LP, Morgan GJ. Extent of parotid disease influences outcome in patients with metastatic cutaneous squamous cell carcinoma. Arch Otolaryngol Head Neck Surg. 2003;129(7):750. doi: 10.1001/archotol.129.7.750. PubMed DOI

Audet N, Palme CE, Gullane PJ, Gilbert RW, Brown DH, Irish J, Neligan P. Cutaneous metastatic squamous cell carcinoma to the parotid gland: analysis and outcome. Head Neck. 2004;26(8):727–732. doi: 10.1002/hed.20048. PubMed DOI

Thom JJ, Moore EJ, Price DL, Kasperbauer JL, Starkman SJ, Olsen KD. The role of total parotidectomy for metastatic cutaneous squamous cell carcinoma and malignant melanoma. JAMA Otolaryngol Head Neck Surg. 2014;140(6):548. doi: 10.1001/jamaoto.2014.352. PubMed DOI

Terakedis BE, Hunt JP, Buchmann LO, Avizonis VN, Anker CJ, Hitchcock YJ. The prognostic significance of facial nerve involvement in carcinomas of the parotid gland. Am J Clin Oncol. 2017;40(3):323–328. doi: 10.1097/COC.0000000000000157. PubMed DOI

Yesensky J, Solis RN, Bewley A. Facial nerve sacrifice during parotidectomy for metastatic cutaneous squamous cell carcinoma. OTO Open. 2021;5(1):2473974X21996627. doi: 10.1177/2473974X21996627. PubMed DOI PMC

Hong TS, Kriesel KJ, Hartig GK, Harari PM. Parotid area lymph node metastases from cutaneous squamous cell carcinoma: Implications for diagnosis, treatment, and prognosis. Head Neck. 2005;27(10):851–856. doi: 10.1002/hed.20256. PubMed DOI